Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus

Biopolymers - Peptide Science Section

Volumn 90, Issue 5, 2008, Pages 611-616

  Simerska, Pavla ^a   Abdel Aal, Abu Baker M ^a   Fujita, Yoshio ^a   Batzloff, Michael R ^b   Good, Michael F ^b   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Carbohydrate; Group A streptococcus; Lipid; Peptide; Vaccine

Indexed keywords

ANTIBODY TITERS; D GALACTOSE; D GLUCOSE; GROUP A STREPTOCOCCUS; IMMUNE SYSTEMS; IN-VIVO; IN-VIVO EXPERIMENTS; OPTIMAL ORIENTATIONS; PEPTIDE EPITOPES;

AMINO ACIDS; ANTIGENS; CARBOHYDRATES; GLUCOSE; ORGANIC ACIDS; VACCINES;

AMINES;

ACRYLONITRILE; BACTERIAL ANTIGEN; DRUG CARRIER; EPITOPE; GALACTOSE; GLUCOSE; IMMUNOLOGICAL ADJUVANT; PEPTIDE; STREPTOCOCCUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C57BL MOUSE; CARBOHYDRATE ANALYSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SYNTHESIS;

ACRYLONITRILE; ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; CARBOHYDRATE SEQUENCE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPITOPES; FEMALE; GALACTOSE; GLUCOSE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 58149187343     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.20992     Document Type: Conference Paper

References (36)

1. Olive, C.; Toth, I.; Jackson, D. Mini-Rev Med Chem 2001, 1, 429-438.
2. Wiesmuller, K. H.; Fleckenstein, B.; Jung, G. Biol Chem 2001, 382, 571-579.
3. Mesa, C.; Fernandez, L. E. Immunol Cell Biol 2004, 82, 644-650.
4. BenMohamed, L.; Wechsler, S. L.; Nesburn, A. B. Lancet Infect Dis 2002, 2, 425-431.
5. Tam, J. P. Proc Natl Acad Sci USA 1988, 85, 5409-5413.
6. Herrera, S.; de Plata, C.; Gonzalez, J. M.; Perlaza, B. L.; Bettens, F.; Corradin, G.; Arevalo-Herrera, M. Parasite Immunol 1997, 19, 161-170.
7. Gibbons, W. A.; Hughes, R. A.; Charalambous, M.; Christodoulou, M.; Szeto, A.; Aulabaugh, A. E.; Mascagni, P.; Toth, I. Liebigs Ann Chem 1990, 12, 1175-1183.
8. Toth, I. J Drug Target 1994, 2, 217-239.
9. Hayman, W. A.; Toth, I.; Flinn, N.; Scanlon, M.; Good, M. F. Immunol Cell Biol 2002, 80, 178-187.
10. Moyle, P. M.; Olive, C.; Ho, M. F.; Good, M. F.; Toth, I. J Med Chem 2006, 49, 6364-6370.
11. Olive, C.; Hsien Kuo, S.; Mei-Fong, H.; Dyer, J.; Horvath, A.; Toth, I.; Good, M. F. J Infect Dis 2006, 194, 316-324.
12. Horvath, A.; Olive, C.; Karpati, L.; Sun, H. K.; Good, M.; Toth, I. J Med Chem 2004, 47, 4100-4104.
13. Olive, C.; Hsien, K.; Horvath, A.; Clair, T.; Yarwood, P.; Toth, I.; Good, M. F. Vaccine 2005, 23, 2298-2303.
14. Pialoux, G.; Gahery-Segard, H.; Sermet, S.; Poncelet, H.; Fournier, S.; Gerard, L.; Tartar, A.; Gras-Masse, H.; Levy, J. P.; Guillet, J. G. AIDS 2001, 15, 1239-1249.
15. Livingston, B. D.; Crimi, C.; Grey, H.; Ishioka, G.; Chisari, F. V.; Fikes, J.; Grey, H.; Chesnut, R. W.; Sette, A. J Immunol 1997, 159, 1383-1392.
16. Lechmann, M. P. D.; Jake Liang, T. M. D. Semin Liver Dis 2000, 20, 211-226.
17. Benmohamed, L.; Thomas, A.; Bossus, M.; Brahimi, K.; Wubben, J.; Gras-Masse, H.; Druilhe, P. Vaccine 2000, 18, 2843-2855.
18. Carapetis, J. R.; Steer, A. C.; Mulholland, E. K.; Weber, M. Lancet Infect Dis 2005, 5, 685-694.
19. Bisno, A. L.; Brito, M. O.; Collins, C. M. Lancet Infect Dis 2003, 3, 191-200.
20. McArthur, J. D.; Walker, M. J Mol Microbiol 2006, 59, 1-4.
21. Olive, C.; Batzloff, M. R.; Toth, I. Exp Rev Vaccine 2004, 3, 43-58.
22. Cunningham, M. W. Clin Microbiol Rev 2000, 13, 470-511.
23. Dale, J. B.; Beachey, E. H. J Exp Med 1985, 161, 113-122.
24. Baird, R. W.; Bronze, M. S.; Kraus, W.; Hill, H. R.; Veasey, L. G.; Dale, J. B. J Immunol 1991, 146, 3132-3137.
25. Bronze, M. S.; Dale, J. B. J Immunol 1993, 151, 2820-2828.
26. Kotloff, K. L.; Corretti, M.; Palmer, K.; Campbell, J. D.; Reddish, M. A.; Hu, M. C.; Wasserman, S. S.; Dale, J. B. JAMA 2004, 292, 709-715.
27. McNeil, S. A.; Halperin, S. A.; Langley, J. M.; Smith, B.; Warren, A.; Sharratt, G. P.; Baxendale, D. M.; Reddish, M. A.; Hu, M. C.; Stroop, S. D.; Linden, J.; Fries, L. F.; Vink, P. E.; Dale, J. B. Clin Infect Dis 2005, 41, 1114-1122.
28. Moyle, P. M.; Olive, C.; Good, M. F.; Toth, I. J Pept Sci 2006, 12, 800-807.
29. Moyle, P. M.; Olive, C.; Karpati, L.; Barozzi, N.; Ho, M. F.; Dyer, J.; Sun, H. K.; Good, M.; Toth, I. Int J Pept Res Ther 2006, 12, 317-326.
30. Horváth, A.; Olive, C.; Wong, A.; Clair, T.; Yarwood, P.; Good, M.; Toth, I. Lett Pept Sci 2001, 8, 285-288.
31. Sarin, V. K.; Kent, S. B. H.; Tam, J. P.; Merrifield, R. B. Anal Biochem 1981, 117, 147-157.
32. Gyorgydeak, Z.; Szilagyi, L.; Paulsen, H. J Carbohydr Chem 1993, 12, 139-163.
33. English, A. R.; Girard, D.; Jasys, V. J.; Martingano, R. J.; Kellogg, M. S. J Med Chem 1990, 33, 344-347.
34. Schnolzer, M.; Alewood, P.; Jones, A.; Alewood, D.; Kent, S. B. H. Int J Pept Protein Res 1992, 40, 180-193.
35. Hayman, W. A.; Brandt, E. R.; Relf, W. A.; Cooper, J.; Saul, A.; Good, M. F. Int Immunol 1997, 9, 1723-1733.
36. Batzloff, M. R.; Yan, H. R.; Davies, M. R.; Hartas, J.; Lowell, G. H.; White, G.; Burt, D. S.; Leanderson, T.; Good, M. F. J Infect Dis 2005, 192, 1450-1455.